Early adopters of biosimilars have paved the way for broader acceptance by sharing real-world success strategies, overcoming initial resistance, and highlighting best practices for integration and ...
Biosimilars could improve access to biologic treatments and health care sustainability in Latin America, but their adoption ...
This webinar celebrating Global Biosimilars Week was hosted by The Center for Biosimilars® in partnership with the International Generics and Biosimilars Association. This webinar celebrating Global ...
Although financial incentives introduced by Japan's 2022 health policy did not result in a reduction in overall drug costs, ...
The European Commission grants marketing authorization to 2 aflibercept biosimilars; Biosimilars Canada launches new campaign ...
I am proposing that all companies currently engaged in developing biosimilars join hands with their regulatory and scientific ...
The article by Sarfaraz K. Niazi, PhD, argues that the FDA’s classification of future copies of messenger RNA (mRNA) products could be reconsidered, suggesting they might be eligible for new drug ...
On this special episode of Not So Different honoring Global Biosimilars Week, Craig Burton, executive director of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback